Expert Pitch
Rutgers University-New Brunswick

How Coronavirus Could Affect Pregnancy

A Rutgers expert discusses risks to pregnant women and unborn children
30-Mar-2020 8:35 AM EDT, by Rutgers University-New Brunswick

Newswise — As the novel coronavirus spreads globally, pregnant women are concerned about how COVID-19 could affect them and their unborn children.

Justin Brandt, an assistant professor of obstetrics and gynecology in the Division of Maternal-Fetal Medicine at Rutgers Robert Wood Medical School, discusses common questions regarding pregnancy and the coronavirus.

Are pregnant women more at risk if they contract COVID-19?

Although preliminary data about COVID-19 and pregnancy was reassuring, we have seen reports in the US of some pregnant women having severe illnesses. However, at this time, it remains unclear whether pregnant women with COVID-19 fare worse than non-pregnant patients or have similar outcomes.

What should a pregnant woman do if she thinks she is infected?

Women should call their obstetrician and let them know their concerns. If symptoms are severe, they may need to be evaluated in the hospital. However, most women, even if pregnant, have mild symptoms and likely will not have to seek medical attention. My colleagues and I are triaging these calls over the phone to ensure that potentially ill patients are evaluated at the hospital while most are staying home.

Patients at home with mild symptoms need to self-quarantine for a minimum of 14 days. They should not go to their routine prenatal visits until they have spoken to their doctor’s office and received instructions. We are encouraging our patients to be forthcoming with symptoms when they call, even mild symptoms, so we can ensure patients get optimal care.

What impact could COVID-19 have on unborn babies?

The clinical picture is changing rapidly. Most reports have suggested that the risk of vertical transmission is low. This means it is unlikely that the virus is transmitted from an infected mother to her fetus. However, it was recently reported that some newborns of mothers with COVID-19 have virus specific antibodies. These antibodies, which are IGM subtype, are not usually transferred across the placenta from mother to fetus due to their large molecular size. This new data has some significant weaknesses, but this finding suggests that antibodies were produced by some babies who were exposed to the novel coronavirus in utero.

We need more data to clarify and corroborate this risk, but there may be reason to worry about vertical transmission and associated conditions, including birth defects, early neonatal disease and other complications. At this time, though, the data is just too limited to comment definitively about this risk, and we may be reassured by data about first trimester infection with SARS, another coronavirus, which suggests the risk is low.

We know that neonatal transmission occurs, and family members and friends with COVID-19 can transmit the infection to children. The majority of cases of COVID-19 involving children, including newborns and babies, have been asymptomatic or mild. We need to prevent these infections, though, because there have been reports of severe disease, even deaths, in children.

How is the medical community trying to reduce the risk to pregnant women and their babies?

At our Rutgers Health practice, we have modified our schedule for prenatal visits and obstetric ultrasounds. We are also using telemedicine as much as possible. We are doing everything we can to provide optimal prenatal care while minimizing the need for patients to leave their homes.

During this time, expecting parents should check with their physicians and the hospitals in which they plan to give birth as visitor policies are changing frequently. Patients may be allowed to have one support person on labor and delivery or, in some cases, may not be allowed any visitor. In addition, many hospitals are screening visitors for fever or illness. Visitors or support persons may not be allowed to enter a hospital if symptomatic or high risk for COVID-19.

Pregnant women who have COVID-19 should expect that they will be temporarily isolated from the baby following delivery. This is in accordance with guidance from the CDC and is intended to minimize the risk of neonatal transmission. The recent report of a neonatal death in Illinois due to complications from COVID-19 underscore the importance of this policy. The baby can receive the mother's breast milk and will be reunited with the mother as soon as transmission-based restrictions are lifted.  

What should pregnant women keep in mind right now?

Pregnant women should adhere to the principals of social distancing, stay home and avoid public gatherings. If parents must leave their homes, we want them to focus on adequate handwashing, trying not to touch their faces and keeping a safe distance of at least six feet from people who may be sick or people whose statuses are unknown.

Expecting parents should prepare to be home for several months. They should have food, common medicines including Tylenol, thermometers and other household items such as soap, toilet paper and washing detergent. When possible, patients should take advantage of delivery services rather than going to markets and other stores where people may congregate. 

It is safe for pregnant women to be home if they develop mild illnesses. Most people who acquire COVID-19 will recover fully with minimal risk. This is true for pregnant women as well. However, symptoms may worsen rapidly. Shortness of breath, coughing up blood, inability to tolerate liquids due to persistent vomiting and changes in mental status such as confusion are symptoms that require urgent medical attention. In addition, obstetrical complaints such as uterine contractions, vaginal bleeding and perceptions of less fetal movement also require evaluation.  


Filters close

Showing results

110 of 2527
Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.

Showing results

110 of 2527